Brief: Asit Biotech FY Net Loss Narrows To 12.0 Million Euros

European Medical Solutions SA

12/02/2018 06:18

Feb 12 (Reuters) - ASIT BIOTECH SA  ASIT.BR : 
    * FY OPERATING LOSS EUR 12.0 MILLION VERSUS LOSS OF EUR 12.3 MILLION YEAR AGO 
    * CLINICAL AND RESEARCH AND DEVELOPMENT PROGRAMS ON TRACK WITH MULTIPLE DEVELOPMENT 
MILESTONES 
EXPECTED IN 2018 
    * CASH POSITION AT END-2017 OF 2.13 MILLION 
    * REDUCTION IN OPERATING EXPENSES IN LINE WITH THE COMPANY'S EXPECTATIONS 
    * FY NET LOSS EUR 12.0 MILLION VERSUS LOSS OF EUR 12.3 MILLION YEAR AGO 
    * 2ND PHASE III GP-ASIT+ TRIAL IN EUROPE IN ADULTS WITH SITE SELECTION IN Q4 2018 
    * FIRST-PATIENT FIRST-VISIT FOR GP-ASIT+ IN Q1 2019 III 
 
Source text for Eikon:  ID:nBw9dxbPxa  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))